1. Baumgartner JD (1990) Arguments for the administration of immunoglobulins in critically-ill patients. In: Peter K, Lawin P, Bein T, Briegel J (eds) Intensivmedizin, vol 76. Thieme, Stuttgart, pp 152–157
2. Baumgartner JD (1991) Prophylactic study of standard intravenous Immunoglobulin and core LPS immunoglobulin in high-risk post surgical patients. Abstract SY 81 2nd International congress on the immune consequences of trauma, shock and sepsis—mechanisms and therapeutic approaches, Munich, 6–9 March. Demeter Gräfelfing, p 26
3. Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA, and the Methylprednisolone Severe Sepsis Study Group (1989) Sepsis syndrome: a valid clinical entity. Crit Care Med 17:389–393
4. Class I, Schorer R (1989) Adjuvant therapy with Pseudomonas hyperimmune globulin. Anasth Intensivther Notfallmed 24:167–171
5. Collins MS, Roby RE (1984) Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa. Am J Med 76, Suppl 3A:168–174